<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Entwistle &amp; Cappucci LLP ("Entwistle &amp; Cappucci") and Susman Godfrey 
 L.L.P. ("Susman Godfrey") today announced that they have filed a 
 securities class action lawsuit on behalf of persons or entities that 
 traded certain derivative securities of Allergan, Inc. AGN 
 ("Allergan" or the "Company") during the period February 25, 2014 
 through April 21, 2014, inclusive (the "Class Period"), and who thereby 
 sustained damages (the "Class"). The case was filed in the United States 
 District Court for the Central District of California, Case No. CV 
 17-04776-DOC (KESx), against Pershing Square Capital Management, L.P., 
 Valeant Pharmaceuticals International, Inc. ("Valeant") and related 
 defendants (collectively, "Defendants").
 
 
 The class action asserts claims under Sections 14(e), 20A and 20(a) of 
 the Securities Exchange Act of 1934 arising from the 2014 attempted 
 acquisition of Allergan by Valeant and its affiliates. The complaint 
 alleges that certain Defendants traded on material non-public 
 information regarding the proposed acquisition, and as a result, Class 
 members that sold Allergan call options, purchased Allergan put options 
 and/or sold Allergan equity forward contracts during the Class Period 
 did so at prices that did not reflect the material nonpublic information 
 known to Defendants. In this action, Plaintiff seeks an award of 
 damages, and prejudgment interest, to Plaintiff and other Class members.
 
 
 If you wish to serve as a lead plaintiff in this matter, you must file a 
 motion with the Court no later than 60 days from today, or by August 29, 
 2017. Any member of the proposed Class may move the Court to serve as a 
 lead plaintiff in this matter through counsel of their choice, or they 
 may choose to do nothing and remain a member of the Class.
 
 
 If you wish to discuss this action or have any questions concerning this 
 notice or your rights or interests, please contact: Andrew J. Entwistle, 
 Esq. of Entwistle &amp; Cappucci at (212) 894-7200 or via e-mail at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:aentwistle@entwistle-law.com" rel="nofollow" rel="nofollow">aentwistle@entwistle-law.com</a>; 
 or Robert N. Cappucci, Esq. of Entwistle &amp; Cappucci at (212) 894-7200 or 
 via e-mail at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:rcappucci@entwistle-law.com" rel="nofollow" rel="nofollow">rcappucci@entwistle-law.com</a>.
 
 
 About Entwistle &amp; Cappucci
 
 
 Entwistle &amp; Cappucci is a national law firm providing exceptional legal 
 representation to clients globally in the most complex and challenging 
 legal matters. Our practice encompasses all areas of litigation, 
 including securities, antitrust, corporate transactions, general 
 corporate and commercial, creditor's rights and bankruptcy, corporate 
 governance and fiduciary duty, government affairs, insurance, 
 investigations and white collar defense. Our clients include public and 
 private corporations, major hedge funds, public pension funds, 
 governmental entities, leading institutional investors, domestic and 
 foreign financial services companies, emerging business enterprises and 
 individual entrepreneurs.
 
 
 About Susman Godfrey
 
 
 For more than 30 years, Susman Godfrey has focused its nationally 
 recognized practice on just one thing: high-stakes commercial 
 litigation. It is one of the nation's leading law firms, with offices in 
 Houston, Seattle, Los Angeles and New York. For more information, visit <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.susmangodfrey.com&amp;esheet=51583141&amp;newsitemid=20170630005603&amp;lan=en-US&amp;anchor=www.susmangodfrey.com&amp;index=1&amp;md5=6a8593127f06fd3a3f28ec40636dabad" rel="nofollow" rel="nofollow">www.susmangodfrey.com</a>.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170630005603r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170630005603/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170630005603/en/</a></body></html>

Press Releases

Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Allergan, Inc. During the Period February 25, 2014 Through April 21, 2014, Inclusive 


Legitify, a leading European remote online notarisation solution has entered into a partnership with Scrive, to offer electronic notarisation to Legitify&#39;s customers.


As pioneers in online notarisation and e-signature

Legitify Partners with Scrive to Offer Electronic Notarisation Services


Company Helps Patients in Need Access Necessary Medications to Stay Healthy


Fifty million Americans don&#39;t take their prescribed medication because they can&#39;t afford it, often making the impossible choice between

PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023


Orion S.A. (NYSE:OEC), a specialty chemical company, today announced that its board of directors has declared an interim dividend to be paid in the third quarter of 2024 of $0.0207 per common share of the company, which

Orion S.A. Declares Interim Quarterly Dividend


AM Best has affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Rating (Long-Term ICR) of &#34;aa+&#34; (Superior) of Berkshire Hathaway Life Insurance Company of Nebraska (BHLN)

AM Best Affirms Credit Ratings of Berkshire Hathaway Life Insurance Company of Nebraska and First Berkshire Hathaway Life Insurance Company


Mettler-Toledo International Inc. (NYSE:MTD) today announced it will webcast its presentation at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 8:40am Pacific Time (11:40pm Eastern Time).

Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2024 Healthcare Conference


FIS® (NYSE:FIS), a global leader in financial technology, announced today a regular quarterly dividend of $0.36 per common share. The dividend is payable on June 24, 2024, to FIS shareholders of record as of close